CHEMICAL AND PHYSICAL PROPERTIES
Physical Description | Solid |
---|---|
Melting Point | 70-72 °C |
Solubility | 451 mg/L |
LogP | 2.81 |
Caco2 Permeability | -4.81 |
Dissociation Constants | 9.21 |
COMPUTED DESCRIPTORS
Molecular Weight | 307.4 g/mol |
---|---|
XLogP3 | 2.8 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 11 |
Exact Mass | 307.21474379 g/mol |
Monoisotopic Mass | 307.21474379 g/mol |
Topological Polar Surface Area | 50.7 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 286 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently-Bonded Unit Count | 1 |
Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Betaxolol is a propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydoxy is substituted by a 4-[2-(cyclopropylmethoxy)ethyl]phenyl group and one of the hydrogens attached to the amino group is substituted by isopropyl. It is a selective beta1-receptor blocker and is used in the treatment of glaucoma as well as hypertension, arrhythmias, and coronary heart disease. It is also used to reduce non-fatal cardiac events in patients with heart failure. It has a role as a beta-adrenergic antagonist, an antihypertensive agent and a sympatholytic agent.